Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Sinopharm Group Co Ltd
OTC:SHTDF
Sinopharm Group Co Ltd
OTC:SHTDF
Price:
2.08
USD
-0.95%
Market Closed
Market Cap:
$6.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sinopharm Group Co Ltd
OTC:SHTDF
|
CN |
|
H
|
HubSpot Inc
SWB:096
|
US |
Wall St Price Targets
SHTDF Price Forecast
Based on 16 analysts
Based on 16 analysts
+45% Upside
from
$2.08
today
Sinopharm Group Co Ltd (SHTDF)’s 12-month stock price forecast through September 2027 has a consensus target of $3.01, implying 45% upside. The forecast is based on price targets from 16 Wall Street analysts.
SHTDF Analyst Rating
No ratings yet
No ratings yet
Sinopharm Group Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SHTDF's stock price target?
Price Target
3.01
USD
3.01
USD
According to Wall Street analysts, the average 1-year price target for SHTDF is 3.01 USD with a low forecast of 2.4 USD and a high forecast of 3.96 USD.
What is the Revenue forecast for Sinopharm Group Co Ltd?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for Sinopharm Group Co Ltd?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 7%.
What is the Pre-Tax Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 7%.